DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Campath (Alemtuzumab) - Pancytopenia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Pancytopenia (13)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Campath (Alemtuzumab) where reactions include pancytopenia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Campath side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-23

Patient: 60 year old female

Reactions: Endophthalmitis, Bronchopulmonary Aspergillosis, Cerebral Artery Embolism, Fungal Endocarditis, Pancytopenia, Infection in AN Immunocompromised Host

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Chronic Lymphocytic Leukaemia

Mycophenolate Mofetil
    Indication: Graft Versus Host Disease

Fludara
    Indication: Chronic Lymphocytic Leukaemia

Campath
    Indication: Chronic Lymphocytic Leukaemia



Possible Campath side effects in 60 year old female

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-06

Patient: 60 year old female

Reactions: Night Sweats, Endophthalmitis, Fungal Endocarditis, Pancytopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Corticosteroid NOS
    Dosage: unk
    Indication: Graft Versus Host Disease

Fludara
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Cyclophosphamide
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia

Mycophenolate Mofetil
    Dosage: unk
    Indication: Graft Versus Host Disease

Campath
    Dosage: unk
    Indication: Chronic Lymphocytic Leukaemia



Possible Campath side effects in female

Reported by a lawyer from United States on 2012-07-20

Patient: female

Reactions: Abdominal Pain, Upper Limb Fracture, Vulval Ulceration, Face Oedema, Upper Respiratory Tract Infection, Phlebolith, Hypotension, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Chest Pain, Bone Disorder, Depression, Bundle Branch Block Left, Discomfort, Impaired Healing, Sepsis, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Hypocalcaemia, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Stomatitis, Pneumonia, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Confusional State, Atelectasis, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Sinusitis, Hallucination, Venous Lake, RIB Fracture, Pain in JAW, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Osteolysis, Rash, Deformity, Facial Pain, Pulmonary Fibrosis, Anxiety, Mucosal Inflammation, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aredia
    Dosage: 90 mg, qmo
    Indication: Multiple Myeloma

Campath
    End date: 2004-09-27

Thalidomide

Other drugs received by patient: Mevacor; COD-Liver OIL; Multivite; Acyclovir; Neurontin; Peridex; Scopolamine; Darvocet-N 50; Tylenol; Magnesium Sulfate; Prednisone TAB; Aspirin; Hydralazine HCL; Calcium; Lovastatin; Ativan; Chemotherapeutics NOS; Procrit / 00909301 /; MS Contin; Solu-Medrol; Augmentin '125'; Revlimid



Possible Campath side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Protein-Losing Gastroenteropathy, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd, on first 3 days of each 28 day cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26

Cyclophosphamide
    Dosage: 360 mg, qd on first 3 days of each 28 day cycle
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26

Fludara
    Dosage: 57.6 mg, qd on first 3 days of each 28 day cycle
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26



Possible Campath side effects in female

Reported by a consumer/non-health professional from France on 2012-04-20

Patient: female, weighing 48.0 kg (105.6 pounds)

Reactions: Protein-Losing Gastroenteropathy, Pancytopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, qd, on first 3 days of each 28 day cycle
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26

Fludara
    Dosage: 57.6 mg, qd on first 3 days of each 28 day cycle
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26

Cyclophosphamide
    Dosage: 360 mg, qd on first 3 days of each 28 day cycle
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2008-10-01
    End date: 2008-11-26



Possible Campath side effects in female

Reported by a lawyer from United States on 2012-04-18

Patient: female

Reactions: Abdominal Pain, Vulval Ulceration, Upper Limb Fracture, Face Oedema, Hypotension, Phlebolith, Pancytopenia, Emotional Distress, Swelling, Abscess, Actinomycosis, Essential Hypertension, Pelvic Pain, Fall, Skin Reaction, Depression, Bone Disorder, Discomfort, Impaired Healing, Escherichia Urinary Tract Infection, Urticaria, Osteomyelitis, Dyspepsia, Vulvovaginal Dryness, Tendonitis, Epistaxis, Breast Pain, Dermatitis Atopic, Pneumonia, Stomatitis, Cellulitis, Clavicle Fracture, Supraventricular Tachycardia, Anaemia, Decreased Interest, Cholelithiasis, Osteosclerosis, Insomnia, Atelectasis, Confusional State, Hypertrophy, Pain, Neuropathy Peripheral, Splenic Granuloma, Bone Marrow Failure, Pleural Effusion, Thrombocytopenia, Hallucination, Sinusitis, Venous Lake, Pain in JAW, RIB Fracture, Abdominal Pain Lower, Blood Pressure Increased, Angioedema, Nausea, Rash, Osteolysis, Deformity, Facial Pain, Pulmonary Fibrosis, Mucosal Inflammation, Anxiety, Osteonecrosis of JAW, Hypophagia, Bronchitis, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Thalidomide

Campath
    Dosage: unk
    End date: 2004-09-27

Aredia
    Dosage: unk ukn, qmo
    Indication: Multiple Myeloma

Other drugs received by patient: Darvocet-N 50; Magnesium; Aspirin; Augmentin '125'; Revlimid; Ativan; Calcium Carbonate; Hydralazine HCL; Prednisone TAB; COD-Liver OIL; Tylenol (Caplet); Chemotherapeutics NOS; Procrit / 00909301 /; Solu-Medrol; Lovastatin; Acyclovir; Neurontin; Peridex; MS Contin; Multivite; Mevacor; Scopolamine



Possible Campath side effects in 60 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-07

Patient: 60 year old male

Reactions: Graft Versus Host Disease, Tuberculosis, Pseudomembranous Colitis, Cytomegalovirus Infection, Epstein-Barr Viraemia, Pancytopenia, Lymphoma

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Neoral
    Dosage: 100 mg, qd
    Indication: Immunosuppression

Myfortic
    Indication: Immunosuppression

Certican
    Dosage: 0.25 mg, bid
    Administration route: Oral

Mabthera
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-01
    End date: 2011-07-01

Mabthera
    Dosage: unk

Neoral
    Dosage: 160 mg, qd
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-03-01
    End date: 2011-06-01

Prograf
    Dosage: unk
    Indication: Graft Versus Host Disease in Skin

Campath
    Dosage: unk
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-07-29
    End date: 2011-08-01

Campath
    Dosage: unk
    Start date: 2011-08-11

Certican
    Dosage: 0.5 mg, bid
    Administration route: Oral
    Indication: Acute Myeloid Leukaemia
    Start date: 2011-06-01
    End date: 2011-08-01

Myfortic
    Dosage: 750 mg, tid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-01
    End date: 2011-06-01



Possible Campath side effects in 64 year old male

Reported by a physician from Italy on 2012-01-03

Patient: 64 year old male

Reactions: Visceral Leishmaniasis, Pancytopenia, Pyrexia, Splenomegaly

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-12-21

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Other drugs received by patient: Pantoprazole Sodium; Cotrim; Acetaminophen; Valaciclovir; Clemastine Fumarate



Possible Campath side effects in male

Reported by a individual with unspecified qualification from United States on 2011-12-05

Patient: male, weighing 61.0 kg (134.3 pounds)

Reactions: Productive Cough, Biopsy Lung Abnormal, Rales, Cardiomegaly, Pericardial Effusion, Oedema Peripheral, Pneumothorax, Cardiac Failure Congestive, Pulmonary Necrosis, Cytomegalovirus Test Positive, Anaemia, Pancytopenia, Fungal Infection, Rhonchi, Dehydration, non-Small Cell Lung Cancer, Confusional State, Atelectasis, Nuchal Rigidity, Fall, Fatigue, Musculoskeletal Stiffness, Pleural Effusion, Abdominal Distension, Sinusitis, Thrombocytopenia, Decreased Appetite, Lethargy, Candidiasis, Dyspnoea, Lung Neoplasm, Jugular Vein Distension, Cerebral Atrophy, Ascites, Disease Recurrence, Hypophagia, Aspergillosis, Bronchitis, Gait Disturbance, Asthenia, Face Injury

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1212 mg

Pentostatin
    Dosage: 8 mg

Campath
    Dosage: 60 mg

Rituximab (Moab C2b8 Anti Cd20, Chimeric)
    Dosage: 758 mg



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-30

Patient: male, weighing 69.2 kg (152.2 pounds)

Reactions: C-Reactive Protein Increased, Atypical Mycobacterial Pneumonia, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    End date: 2011-10-07

Campath
    Dosage: 1st cycle 30 mg, 3x/w monday, wednesday, friday
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-07-24

Dexamethasone
    Dosage: 40 mg, qd 1-4
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27

Dexamethasone
    Dosage: 40 mg, qd 15-18
    Administration route: Oral
    End date: 2011-10-03

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Cotrim; Valaciclovir; Paracetamol



Possible Campath side effects in male

Reported by a physician from Germany on 2011-11-16

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Clemastine Fumarate; Pantoprazole Sodium; Acetaminophen; Cotrim; Valaciclovir



Possible Campath side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2011-10-27

Patient: male, weighing 66.0 kg (145.2 pounds)

Reactions: C-Reactive Protein Increased, Pancytopenia, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, qd
    Administration route: Oral
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-06

Campath
    Dosage: 30 mg, 3x/w
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-06-27
    End date: 2011-10-07

Pegfilgrastim
    Dosage: 6 mg, qd
    Indication: Neutropenia
    Start date: 2011-06-27
    End date: 2011-10-03

Other drugs received by patient: Pantoprazole Sodium; Valaciclovir; Clemastine Fumarate; Cotrim; Acetaminophen

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017